Suchergebnisse - "Kakutani, Shigenori"

PubPharm (37)

1

Development of risk-score model in patients with negative surgical margin after robot-assisted radical prostatectomy

enthalten in: Scientific reports | 2024

von Yamada, Y. | Fujii, Y. | Kakutani, S. | +19

2

Enfortumab vedotin versus platinum rechallenge in post-platinum, post-pembrolizumab advanced urothelial carcinoma : A multicenter propensity score-matched study

enthalten in: International journal of urology : official journal of the Japanese Urological Association | 2023

von Taguchi, S. | Kawai, T. | Ambe, Y. | +24

3

Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab

enthalten in: Immunotherapy | 2023

von Taguchi, S. | Kawai, T. | Buti, S. | +26

4

Improved survival in real-world patients with advanced urothelial carcinoma : A multicenter propensity score-matched cohort study comparing a period before the introduction of pembrolizumab (2003-2011) and a more recent period (2016-2020)

enthalten in: International journal of urology : official journal of the Japanese Urological Association | 2022

von Taguchi, S. | Kawai, T. | Nakagawa, T. | +29

5

Prognostic Significance of the Albumin-to-globulin Ratio for Advanced Urothelial Carcinoma Treated with Pembrolizumab: A Multicenter Retrospective Study

enthalten in: ResearchSquare.com | 2022

von Taguchi, S. | Kawai, T. | Nakagawa, T. | +15

6

Clinical characteristics of patients with inguinal hernia mesh migration into the bladder

enthalten in: IJU case reports | 2022

von Akimoto, T. | Kakutani, S. | Kamei, J. | +3

7

Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma : a multicenter retrospective study using time-dependent analysis

enthalten in: Journal for immunotherapy of cancer | 2022

von Kawai, T. | Taguchi, S. | Nakagawa, T. | +15

8

Improved survival in real‐world patients with advanced urothelial carcinoma : A multicenter propensity score‐matched cohort study comparing a period before the introduction of pembrolizumab (2003–2011) and a more recent period (2016–2020)

enthalten in: International Journal of Urology | 2022

von Taguchi, S. | Kawai, T. | Nakagawa, T. | +29

9

Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab : a multicenter retrospective study

enthalten in: Scientific reports | 2021

von Taguchi, S. | Kawai, T. | Nakagawa, T. | +15

10

Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy

enthalten in: BMC cancer | 2021

von Takeshima, Y. | Yamada, Y. | Teshima, T. | +9